InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-29.7%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Harsch Mutya, Directrice Juridique et GC. Insider active across 1 company, notably VYNE Therapeutics Inc.. Cumulatively, 25 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €23k. History available since 30 June 2021. The latest transaction was filed on 31 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations25 total
8,828 shares@ US$1.5812.8% of flowCommon StockSEC:0001415889-25-009631:0
4,697 shares@ US$3.3515.0% of flowCommon StockSEC:0001415889-25-000154:0
105 shares@ US$1.880.2% of flowCommon StockSEC:0001415889-24-024381:0
143 shares@ US$1.920.3% of flowCommon StockSEC:0001415889-24-019174:0
161 shares@ US$3.080.5% of flowCommon StockSEC:0001415889-24-010067:0
62,500 shares0Common StockSEC:0001209191-24-000467:0
62,500 shares0Common StockSEC:0001209191-23-058817:0
1,154 shares@ US$3.834.2% of flowCommon StockSEC:0001209191-23-051944:0
157 shares@ US$4.100.6% of flowCommon StockSEC:0001209191-23-041107:0
3,664 shares@ US$3.456311.7% of flowCommon StockSEC:0001209191-23-033802:0
478 shares@ US$3.081.3% of flowCommon StockSEC:0001209191-23-022798:0
10,000 shares@ US$2.5023.2% of flowCommon StockSEC:0001209191-23-020477:0
Ideal exit: 15 Dec 2023 (T+270)
1,813 shares@ US$0.150.3% of flowCommon StockSEC:0001209191-23-001111:0
1,813 shares@ US$0.2230.4% of flowCommon StockSEC:0001209191-22-052353:0
1,813 shares@ US$0.3890.7% of flowCommon StockSEC:0001209191-22-040783:0
3,630 shares@ US$0.650.011% mcap7.3% of flowCommon StockSEC:0001209191-22-022526:0
75,000 shares0Common StockSEC:0001209191-22-020065:0
1,484 shares@ US$1.021.3% of flowCommon StockSEC:0001209191-22-000855
1,484 shares@ US$1.020.0069% mcap4.5% of flowCommon StockSEC:0001209191-22-000855:0
1,484 shares@ US$1.391.8% of flowCommon StockSEC:0001209191-21-058516
1,484 shares@ US$1.390.0092% mcap6.1% of flowCommon StockSEC:0001209191-21-058516:0
60,859 shares0Common StockSEC:0001209191-21-054834:0
60,859 shares0Common StockSEC:0001209191-21-054834
3,551 shares@ US$3.5110.4% of flowCommon StockSEC:0001209191-21-044977
3,551 shares@ US$3.510.054% mcap35.8% of flowCommon StockSEC:0001209191-21-044977:0
25 of 25 declarations
About Harsch Mutya
Mutya Harsch is the Chief Legal Officer and GC at VYNE Therapeutics Inc. She oversees the company's legal and compliance matters. Her role is essential in ensuring that the company adheres to current regulations.
